Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 132
interventional 99
Observational 30
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Behavioral 17
Drug 17
Biological 11
Device 10
Other 9
Drug|Other 4
Biological|placebo 3
Drug|placebo 3
Biological|Drug|Other 2
Device|Drug 2
Dietary Supplement|placebo 2
Drug|Other|Procedure|Radiation 2
Procedure|Radiation 2
Radiation 2
Behavioral|Biological 1
Behavioral|Procedure|Radiation 1
Biological|Drug 1
Biological|Drug|Other|Radiation 1
Biological|Other|Procedure 1
Dietary Supplement 1
Dietary Supplement|Other|placebo 1
Drug|placebo|Procedure 1
Drug|Procedure 1
Drug|Procedure|Radiation 1
Drug|Radiation 1
Other|Procedure 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 64
NA 8
China 3
Belgium 2
Czech Republic 2
Czechia 2
Spain 2
United States|Australia 2
Australia 1
Belgium|Finland|France|Germany|Netherlands|Spain|United Kingdom 1
Belgium|Germany|Netherlands 1
Canada 1
Cuba 1
France 1
Japan 1
Kenya 1
Madagascar 1
Netherlands 1
South Africa 1
Tanzania 1
Turkey 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 72
2 7
5 2
6 3
7 3
8 3
9 2
12 2
14 1
20 1
40 1
58 1
61 1

Phase

Phase Study_Count
N/A 39
Phase 2 25
Phase 1 16
Phase 3 8
Phase 1/Phase 2 6
Phase 4 4
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 36
2 36
3 7
4 7
5 2
6 4
10 1
16 1
NA 5

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 1306 3.00 8.000 25.00000 7.00 51.00 19.00
1st Qu. 1306 123.00 17.500 42.00000 28.00 205.25 79.75
Median 1306 240.00 28.000 64.50000 62.00 385.00 125.00
Mean 1306 3963.59 38.625 73.16667 95.72 1902.00 195.25
3rd Qu. 1306 924.00 41.500 91.50000 110.00 978.50 240.50
Max. 1306 53414.00 158.000 150.00000 511.00 12000.00 512.00

Trial Group Type

group_type Group_Count
Experimental 149
Active Comparator 37
No Intervention 14
Placebo Comparator 10
Other 6
NA 5
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 46
Single Group Assignment 42
Sequential Assignment 6
Crossover Assignment 2
Factorial Assignment 2
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 48
Prevention 22
Health Services Research 12
Diagnostic 11
Other 2
Supportive Care 2
Basic Science 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 12
NA 4
Belgium 3
Thailand 2
Turkey 2
United States|Puerto Rico 2
Brazil 1
Denmark 1
Germany 1
South Africa 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 23
2 3
3 1
7 1
23 1
51 1

Enrollment Metrics

Measure Observational
Min 15.0
1st Qu 66.0
Median 158.0
Mean 5532.8
3rd Qu 400.0
Max 114035.0

Observation Model

observational_model Study_Count
Cohort 16
NA 4
Case-Control 3
Case-Only 3
Other 2
Case Control 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 19
Retrospective 4
Cross-Sectional 3
Other 2
NA 2

Registries

Studies by Country

Country Study_Count
Turkey 1
United Kingdom 1
United States 1

Sites per Study

Site_count Study_Count
1 2
44 1

Enrollment Metrics

Measure Registries
Min 239.0
1st Qu 319.5
Median 400.0
Mean 713.0
3rd Qu 950.0
Max 1500.0

Registry Model

observational_model Study_Count
Cohort 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 3

Follow-up

target_duration Study_Count
32 Months 1
4 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03350698 Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination https://ClinicalTrials.gov/show/NCT03350698 Recruiting Eastern Virginia Medical School 2020-06-14
NCT03824093 High and Low Resource Interventions to Promote HPV Vaccines https://ClinicalTrials.gov/show/NCT03824093 Enrolling by invitation Children’s Mercy Hospital Kansas City 2019-12-31
NCT03302858 A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand https://ClinicalTrials.gov/show/NCT03302858 Recruiting Laser Surgery Care 2019-10-31
NCT03239223 Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection https://ClinicalTrials.gov/show/NCT03239223 Completed Antiva Biosciences 2018-10-30
NCT03224000 Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT03224000 Recruiting M.D. Anderson Cancer Center 2025-01-31
NCT03202992 Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection https://ClinicalTrials.gov/show/NCT03202992 Completed Antiva Biosciences 2019-02-04
NCT03186430 PreTeenVax Evaluation https://ClinicalTrials.gov/show/NCT03186430 Completed Emory University 2018-07-31
NCT03162224 Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT03162224 Active, not recruiting MedImmune LLC 2021-03-19
NCT03100045 Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) https://ClinicalTrials.gov/show/NCT03100045 Recruiting Johns Hopkins University 2020-09-30
NCT02834637 A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls https://ClinicalTrials.gov/show/NCT02834637 Active, not recruiting London School of Hygiene and Tropical Medicine 2020-11-30
NCT02811367 The HPV Self-test as a Test of Cure in Madagascar https://ClinicalTrials.gov/show/NCT02811367 Completed University Hospital, Geneva 2016-09-30
NCT02733068 A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. https://ClinicalTrials.gov/show/NCT02733068 Active, not recruiting Shanghai Zerun Biotechnology Co.,Ltd 2018-12-31
NCT02632344 Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement https://ClinicalTrials.gov/show/NCT02632344 Active, not recruiting Massachusetts General Hospital 2020-10-31
NCT03391921 Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) https://ClinicalTrials.gov/show/NCT03391921 Recruiting Centre Hospitalier Universitaire Saint Pierre 2020-01-08
NCT02546752 Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine https://ClinicalTrials.gov/show/NCT02546752 Completed Regenstrief Institute, Inc. 2016-05-31
NCT02489617 The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy https://ClinicalTrials.gov/show/NCT02489617 Recruiting Dana-Farber Cancer Institute 2020-06-30
NCT02405533 Phase II Evaluation of AHCC for the Eradication of HPV Infections https://ClinicalTrials.gov/show/NCT02405533 Active, not recruiting The University of Texas Health Science Center, Houston 2019-02-28
NCT02258659 Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT02258659 Active, not recruiting University of Chicago 2018-12-31
NCT02217358 Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions https://ClinicalTrials.gov/show/NCT02217358 Completed University Hospital Ostrava 2016-03-31
NCT02207439 A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma of the Head and Neck https://ClinicalTrials.gov/show/NCT02207439 Active, not recruiting Abramson Cancer Center of the University of Pennsylvania 2020-12-31
NCT02159703 A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT02159703 Completed Abramson Cancer Center of the University of Pennsylvania 2018-02-28
NCT02124252 Community-Driven Cervical Cancer Prevention in Western Kenya https://ClinicalTrials.gov/show/NCT02124252 Completed Duke University 2016-10-31
NCT02114385 A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) https://ClinicalTrials.gov/show/NCT02114385 Completed Merck Sharp & Dohme Corp. 2015-04-22
NCT02072148 The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) https://ClinicalTrials.gov/show/NCT02072148 Recruiting Icahn School of Medicine at Mount Sinai 2020-10-31
NCT02067507 Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County https://ClinicalTrials.gov/show/NCT02067507 Completed University of California, Los Angeles 2019-10-31
NCT02048020 Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer https://ClinicalTrials.gov/show/NCT02048020 Completed Jonsson Comprehensive Cancer Center 2017-01-09
NCT01988948 Dynamics of Human PApilloma Virus Interactions; Internet-based Students HeAlth Research Enterprise https://ClinicalTrials.gov/show/NCT01988948 Completed Institut Pasteur 2016-06-30
NCT03351855 HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV https://ClinicalTrials.gov/show/NCT03351855 Recruiting Shenzhen Geno-Immune Medical Institute 2019-07-31
NCT01957878 Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL https://ClinicalTrials.gov/show/NCT01957878 Completed Genticel 2016-10-31
NCT01946139 Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV https://ClinicalTrials.gov/show/NCT01946139 Completed AIDS Malignancy Consortium 2018-10-31
NCT01924117 Genotypification and Predisposing Factors in Human Papilloma Virus Infection https://ClinicalTrials.gov/show/NCT01924117 Completed Materno-Perinatal Hospital of the State of Mexico 2011-05-31
NCT01908517 Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study https://ClinicalTrials.gov/show/NCT01908517 Completed East Carolina University 2016-05-31
NCT01901770 The Parents in Appalachia Receive Education Needed for Teen Project https://ClinicalTrials.gov/show/NCT01901770 Active, not recruiting Ohio State University Comprehensive Cancer Center 2020-12-31
NCT01898494 Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer https://ClinicalTrials.gov/show/NCT01898494 Active, not recruiting Eastern Cooperative Oncology Group 2020-02-29
NCT01862874 Efficacy and Tolerability Study of V501 in Japanese Males (V501-122) https://ClinicalTrials.gov/show/NCT01862874 Completed Merck Sharp & Dohme Corp. 2017-08-30
NCT01827423 Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava https://ClinicalTrials.gov/show/NCT01827423 Completed University Hospital Ostrava 2011-12-31
NCT01806714 Text Reminders to Immunize in a Managed Care Organization https://ClinicalTrials.gov/show/NCT01806714 Completed University of Rochester 2014-12-31
NCT01806675 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy https://ClinicalTrials.gov/show/NCT01806675 Completed Stanford University 2016-12-07
NCT01757392 Candin Safety & Efficacy Study for the Treatment of Warts https://ClinicalTrials.gov/show/NCT01757392 Completed Nielsen BioSciences, Inc. 2014-12-31
NCT01637194 Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01637194 Completed Fox Chase Cancer Center 2011-07-31
NCT01461408 Promoting Human Papillomavirus (HPV) Vaccination Through African American Beauty Salons https://ClinicalTrials.gov/show/NCT01461408 Completed MEE Productions, Inc. 2013-07-31
NCT01375868 Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT01375868 Completed Institute of Hematology and Blood Transfusion, Czech Republic 2018-12-31
NCT04398433 INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) https://ClinicalTrials.gov/show/NCT04398433 Recruiting Inovio Pharmaceuticals 2023-07-31
NCT04368455 Virtual Immersive Communication Training on Recommending Immunizations https://ClinicalTrials.gov/show/NCT04368455 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-12-31
NCT04208269 A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3 https://ClinicalTrials.gov/show/NCT04208269 Completed University of Florida 2014-04-01
NCT04199078 Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. https://ClinicalTrials.gov/show/NCT04199078 Recruiting Procare Health Iberia S.L. 2020-06-30
NCT04178174 Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer https://ClinicalTrials.gov/show/NCT04178174 Recruiting Centre hospitalier de l’Université de Montréal (CHUM) 2023-12-31
NCT04113902 The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors https://ClinicalTrials.gov/show/NCT04113902 Completed Saglik Bilimleri Universitesi Gulhane Tip Fakultesi 2019-04-15
NCT04002154 Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV https://ClinicalTrials.gov/show/NCT04002154 Completed Procare Health Iberia S.L. 2018-07-31
NCT03987490 Usability of HPV Vaccine Reminders https://ClinicalTrials.gov/show/NCT03987490 Completed University of Florida 2016-08-01
NCT03944915 De-Escalation Therapy for Human Papillomavirus Negative Disease https://ClinicalTrials.gov/show/NCT03944915 Recruiting University of Chicago 2022-07-01
NCT03943875 GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose https://ClinicalTrials.gov/show/NCT03943875 Recruiting The University of Texas Medical Branch, Galveston 2022-02-28
NCT03925285 Image Guided Surgery in Sinonasal Inverted Papilloma https://ClinicalTrials.gov/show/NCT03925285 Recruiting University Medical Center Groningen 2020-07-01
NCT03903952 Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS? https://ClinicalTrials.gov/show/NCT03903952 Completed Sanliurfa Mehmet Akif Inan Education and Research Hospital 2015-05-30
NCT03759236 Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging https://ClinicalTrials.gov/show/NCT03759236 Completed University of California, Los Angeles 2020-02-19
NCT03747302 HPV Message Testing and Social Media Campaign https://ClinicalTrials.gov/show/NCT03747302 Completed Dartmouth-Hitchcock Medical Center 2019-09-09
NCT03735290 A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer https://ClinicalTrials.gov/show/NCT03735290 Recruiting Immunicum AB 2022-12-31
NCT03734003 Infrared Bioeffect System for the Treatment of Cutaneous Warts https://ClinicalTrials.gov/show/NCT03734003 Recruiting First Hospital of China Medical University 2019-03-25
NCT03729518 TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck https://ClinicalTrials.gov/show/NCT03729518 Recruiting Abramson Cancer Center of the University of Pennsylvania 2022-10-11
NCT03346915 Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention https://ClinicalTrials.gov/show/NCT03346915 Completed Boston Medical Center 2019-04-19
NCT03707587 M7824 in People With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT03707587 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-07-07
NCT03697226 Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. https://ClinicalTrials.gov/show/NCT03697226 Recruiting Antiva Biosciences 2020-06-01
NCT03628885 An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination https://ClinicalTrials.gov/show/NCT03628885 Completed Indiana University 2018-09-27
NCT03604393 Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise https://ClinicalTrials.gov/show/NCT03604393 Active, not recruiting Oregon Health and Science University 2022-12-31
NCT03584308 Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal https://ClinicalTrials.gov/show/NCT03584308 Completed Catalysis SL 2018-05-15
NCT03525210 Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients https://ClinicalTrials.gov/show/NCT03525210 Active, not recruiting Universitaire Ziekenhuizen Leuven 2019-09-30
NCT03497936 Marketability of a Technology-based Intervention to Increase HPV Vaccination https://ClinicalTrials.gov/show/NCT03497936 Recruiting Real Prevention, LLC 2020-05-31
NCT03436251 Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias https://ClinicalTrials.gov/show/NCT03436251 Enrolling by invitation First Hospital of China Medical University 2020-05-08
NCT03427411 M7824 in Subjects With HPV Associated Malignancies https://ClinicalTrials.gov/show/NCT03427411 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT01020747 Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) https://ClinicalTrials.gov/show/NCT01020747 Completed Massachusetts General Hospital 2011-03-31
NCT00964210 Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination https://ClinicalTrials.gov/show/NCT00964210 Completed Murdoch Childrens Research Institute 2010-12-31
NCT00851643 Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) https://ClinicalTrials.gov/show/NCT00851643 Completed Merck Sharp & Dohme Corp. 2007-12-31
NCT02558803 HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 https://ClinicalTrials.gov/show/NCT02558803 Completed Regenstrief Institute, Inc. 2016-05-31
NCT01901562 Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge https://ClinicalTrials.gov/show/NCT01901562 Active, not recruiting Montefiore Medical Center 2021-05-31
NCT02859454 Avelumab for People With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT02859454 Active, not recruiting National Institutes of Health Clinical Center (CC) 2018-06-30
NCT02592902 Recurrent Respiratory Papillomatosis and Extraesophageal Reflux https://ClinicalTrials.gov/show/NCT02592902 Completed University Hospital Ostrava 2018-08-31
NCT02576054 Safety and Tolerability Study of V501 in Japanese Boys (V501-200) https://ClinicalTrials.gov/show/NCT02576054 Completed Merck Sharp & Dohme Corp. 2018-08-08
NCT02551887 HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts https://ClinicalTrials.gov/show/NCT02551887 Completed Regenstrief Institute, Inc. 2015-04-30
NCT01729429 An Intervention Promoting HPV Vaccination in Safety-net Clinics https://ClinicalTrials.gov/show/NCT01729429 Completed University of Texas Southwestern Medical Center 2012-11-30
NCT00715234 Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients https://ClinicalTrials.gov/show/NCT00715234 Completed University of Colorado, Denver 2009-12-31
NCT00572832 Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting https://ClinicalTrials.gov/show/NCT00572832 Completed University of Pittsburgh 2009-04-30
NCT00571701 Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT00571701 Completed Northwell Health 2015-01-31
NCT00492089 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00492089 Completed National Cancer Institute (NCI) 2010-08-31
NCT00470496 Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00470496 Completed Roswell Park Cancer Institute 2011-10-28
NCT00454181 Treatment of Oral Warts in HIV+ Patients https://ClinicalTrials.gov/show/NCT00454181 Completed Amarillo Biosciences, Inc. 2009-09-30
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00303823 Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia https://ClinicalTrials.gov/show/NCT00303823 Completed National Cancer Institute (NCI) 2010-11-30
NCT00205374 Use of Cidofovir for Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT00205374 Completed University of Wisconsin, Madison 2009-12-31
NCT00798265 A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults https://ClinicalTrials.gov/show/NCT00798265 Completed National Institutes of Health Clinical Center (CC) 2012-09-22
NCT00101348 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00101348 Completed National Cancer Institute (NCI) 2007-10-31
NCT00089362 Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors https://ClinicalTrials.gov/show/NCT00089362 Completed National Cancer Institute (NCI) 2008-01-31
NCT00068497 Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00068497 Completed National Cancer Institute (NCI) 2007-12-31
NCT00054041 Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia https://ClinicalTrials.gov/show/NCT00054041 Completed National Cancer Institute (NCI) 2007-01-31
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00030498 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction https://ClinicalTrials.gov/show/NCT00030498 Completed National Cancer Institute (NCI) 2007-07-31
NCT00023959 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00023959 Completed National Cancer Institute (NCI) 2010-03-31
NCT00038714 A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis https://ClinicalTrials.gov/show/NCT00038714 Completed Nventa Biopharmaceuticals Corporation NA
NCT00001126 Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) https://ClinicalTrials.gov/show/NCT00001126 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00709891 Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease https://ClinicalTrials.gov/show/NCT00709891 Completed Hoffmann-La Roche 2013-06-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03542227 Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine https://ClinicalTrials.gov/show/NCT03542227 Active, not recruiting Universiteit Antwerpen 2020-12-15
NCT03418909 Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03418909 Active, not recruiting Rigshospitalet, Denmark 2020-03-31
NCT03082950 HPV Infections, Cancer of the Vulva and Therapeutical Success https://ClinicalTrials.gov/show/NCT03082950 Completed University of Luebeck 2017-12-31
NCT02897232 Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination https://ClinicalTrials.gov/show/NCT02897232 Active, not recruiting Louisiana State University Health Sciences Center Shreveport 2017-03-31
NCT02841631 Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue https://ClinicalTrials.gov/show/NCT02841631 Recruiting University of Derby 2020-07-31
NCT02714114 Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study) https://ClinicalTrials.gov/show/NCT02714114 Completed Universiteit Antwerpen 2015-12-31
NCT02634190 Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens https://ClinicalTrials.gov/show/NCT02634190 Active, not recruiting Hologic Deutschland GmbH 2023-04-30
NCT01304966 Human Papillomatosis Genotyping of Children in Thailand https://ClinicalTrials.gov/show/NCT01304966 Completed Queen Sirikit National Institute of Child Health 2012-09-30
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01567813 Post-Licensure Study of the Safety of GARDASILâ„¢ in Males (V501-070) https://ClinicalTrials.gov/show/NCT01567813 Completed Merck Sharp & Dohme Corp. 2019-06-01
NCT01446198 Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System https://ClinicalTrials.gov/show/NCT01446198 Completed Gen-Probe, Incorporated 2012-05-31
NCT04391647 Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples https://ClinicalTrials.gov/show/NCT04391647 Recruiting Universiteit Antwerpen 2020-07-31
NCT04117386 Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium https://ClinicalTrials.gov/show/NCT04117386 Recruiting Chulalongkorn University 2020-05-31
NCT04023955 Promoting HPV Vaccine Through Twitter https://ClinicalTrials.gov/show/NCT04023955 Completed Tufts University 2018-06-10
NCT03895905 Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity https://ClinicalTrials.gov/show/NCT03895905 Completed Kanuni Sultan Suleyman Training and Research Hospital 2018-12-01
NCT03837028 The Human Papilloma Virus Effect on Sexual Life https://ClinicalTrials.gov/show/NCT03837028 Completed Bakirkoy Dr. Sadi Konuk Research and Training Hospital 2018-06-01
NCT03709602 SDH of HPV Vaccine Completion https://ClinicalTrials.gov/show/NCT03709602 Completed Duke University 2019-12-17
NCT03638427 Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood https://ClinicalTrials.gov/show/NCT03638427 Enrolling by invitation Stanford University 2020-10-01
NCT03474211 Prevalence of HPV Infection Using Self-sampling https://ClinicalTrials.gov/show/NCT03474211 Completed University Hospital, Geneva 2017-01-31
NCT01206556 IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody https://ClinicalTrials.gov/show/NCT01206556 Completed International Maternal Pediatric Adolescent AIDS Clinical Trials Group 2012-12-31
NCT01192282 Typing of Human Papilloma Virus (HPV) From Female Genital Warts https://ClinicalTrials.gov/show/NCT01192282 Completed University of Cape Town 2011-12-31
NCT01030562 Immunogenicity of Off-Schedule Dosing of HPV Vaccine https://ClinicalTrials.gov/show/NCT01030562 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2014-03-05
NCT01539668 Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas https://ClinicalTrials.gov/show/NCT01539668 Completed Barretos Cancer Hospital 2012-12-31
NCT00767897 The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients https://ClinicalTrials.gov/show/NCT00767897 Active, not recruiting Indiana University 2018-12-31
NCT00730704 Acceptance of Human Papillomavirus Vaccination in Postpartum Women https://ClinicalTrials.gov/show/NCT00730704 Completed Columbia University 2012-10-31
NCT00550914 Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP https://ClinicalTrials.gov/show/NCT00550914 Completed Massachusetts Eye and Ear Infirmary NA
NCT00266266 Human Papilloma Virus DNA Self-Test https://ClinicalTrials.gov/show/NCT00266266 Completed University of Louisville 2008-10-31
NCT00179361 Natural History of Oro-pharyngeal Cancer Precursors https://ClinicalTrials.gov/show/NCT00179361 Completed Albert Einstein College of Medicine 2014-07-31
NCT00006444 The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women https://ClinicalTrials.gov/show/NCT00006444 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001603 The Effects of Upper Airway and Digestive Tract Tumors on the Immune System https://ClinicalTrials.gov/show/NCT00001603 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04397081 Atopic Diseases & Human Papilloma Virus https://ClinicalTrials.gov/show/NCT04397081 Completed Adana Numune Training and Research Hospital 2020-02-29
NCT03644563 Men and Women Offering Understanding of Throat HPV https://ClinicalTrials.gov/show/NCT03644563 Recruiting Johns Hopkins Bloomberg School of Public Health 2024-04-30
NCT03465280 Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) https://ClinicalTrials.gov/show/NCT03465280 Recruiting Newcastle-upon-Tyne Hospitals NHS Trust 2020-08-31